TY  - JOUR
AU  - Vignier, Nicolas
AU  - Bouchaud, Olivier
AU  - Angheben, Andrea
AU  - Bottieau, Emmanuel
AU  - Calleri, Guido
AU  - Salas-Coronas, Joaquín
AU  - Martin, Charlotte
AU  - Ramos, José Manuel
AU  - Mechain, Matthieu
AU  - Rapp, Christophe
AU  - Nothdurft, Hans-Dieter
AU  - Velasco, Maria
AU  - Bardají, Azucena
AU  - Rojo-Marcos, Gerardo
AU  - Visser, Leo G
AU  - Hatz, Christoph
AU  - Bisoffi, Zeno
AU  - Jelinek, Tomas
AU  - Duparc, Stephan
AU  - Bourhis, Yann
AU  - Tommasini, Silva
AU  - Iannucelli, Maurizio
AU  - Bacchieri, Antonella
AU  - Mattera, Giovan Giuseppe
AU  - Merlo Pich, Emilio
AU  - Behrens, Ronald H
PY  - 2021
DO  - 10.1186/s12936-021-03750-x
UR  - http://hdl.handle.net/10668/17764
T2  - Malaria journal
AB  - European travellers to endemic countries are at risk of malaria and may be affected by a different range of co-morbidities than natives of endemic regions. The safety profile, especially cardiac issues, of artenimol (previously...
LA  - en
KW  - Adverse events
KW  - Artemisinin
KW  - Artenimol
KW  - Eurartesim
KW  - Imported malaria
KW  - Piperaquine
KW  - Plasmodium falciparum
KW  - QTc prolongation
KW  - Safety
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Artemisinins
KW  - Belgium
KW  - Child
KW  - Child, Preschool
KW  - Communicable Diseases, Imported
KW  - Drug Combinations
KW  - Female
KW  - France
KW  - Germany
KW  - Humans
KW  - Italy
KW  - Longitudinal Studies
KW  - Malaria, Falciparum
KW  - Male
KW  - Middle Aged
KW  - Quinolines
KW  - Registries
KW  - Spain
KW  - United Kingdom
KW  - Young Adult
TI  - Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
TY  - research article
VL  - 20
ER  -